Letter to the Editor: CD14+HLA-DR+ Cells in Patients May Be a Biomarker Reflecting the Progression of COVID-19.

Yang, Mengyuan; Liu, Zhiyu; Kang, Kai; Yu, Kaijiang; Wang, Changsong

Letter to the Editor: CD14⁺HLA-DR⁺ Cells in Patients May Be a Biomarker Reflecting the Progression of COVID-19.

Yang, Mengyuan; Liu, Zhiyu; Kang, Kai; Yu, Kaijiang; Wang, Changsong.

Yang M; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Liu Z; Department of Laboratory Diagnostics, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Kang K; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yu K; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Wang C; Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin, China.

Viral Immunol ; 34(8): 579-581, 2021 10.

Article in English | MEDLINE | ID: covidwho-1470112

Subject(s)

Biomarkers; COVID-19; HLA-DR Antigens/metabolism; Lipopolysaccharide Receptors/metabolism; Humans; Intensive Care Units; Interleukin-6; Monocytes; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biomarkers / HLA-DR Antigens / Lipopolysaccharide Receptors / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Viral Immunol Journal subject: Allergy and Immunology / Virology Year: 2021 Document Type: Article Affiliation country: Vim.2021.0009

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google